Professor David G I Scott
MD, FRCP
NRAS Chief Medical Advisor
Norfolk & Norwich University Hospital NHS Trust
David G I Scott was appointed Consultant Rheumatologist at the Norfolk and Norwich (University) Hospital in February 1988. He was Director of Research and Development for the Trust from 1996 to May 2006 and was made Honorary Professor to the University of East Anglia (UEA) in 1998. He held the post of Divisional Clinical Director for Medicine in the Trust from May 2006 to July 2007 and was appointed Clinical Director of the Norfolk and Suffolk Comprehensive Local Research Network in August 2007.
David graduated from Bristol in 1973 and undertook junior doctor training in Southampton, Bristol, Bath and Birmingham, completing an MD on systemic vasculitis in 1981.
He was President of the British Society for Rheumatology (BSR) from 2002 to 2004, contributing significantly to the successful development and registration of patients on the BSR Biologics Register; he was also Chair of the Joint Specialty Committee for Rheumatology, linking the BSR with the Royal College of Physicians (RCP) 2002-2006. David was elected to Council of the RCP in 2004 and significantly contributed to the RCP working party on Medical Professionalism and the Clinical Standards Board. He is currently working for the RCP as the Patient Involvement Officer (2007 -).
David is a Companion Fellow to the British Orthopaedic Association and undertakes a number of editorial activities. Previous appointments include Medical Secretary to the Arthritis Research Campaign (arc) and membership of the arc Scientific Co-ordinating Committee. He is currently C hair of the arc Research and Academic Capacity Committee (2008- ) and is Medical Adviser to two charities; NRAS (now Chief Medical Adviser) and the Raynaud’s and Scleroderma Association.
He has a long-standing interest in systemic vasculitis, and has written over 250 reviews/editorials and papers in total, including clinical aspects, epidemiology and outcome, and lectures nationally and internationally on this subject. Other research interests include epidemiology of rheumatoid arthritis (Norfolk Arthritis Register) and clinical, health economic and psychosocial aspects of inflammatory arthritis including their relevance to the introduction of anti-TNF alpha therapy.
